Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Debt (2016 - 2025)

Collegium Pharmaceutical has reported Total Debt over the past 10 years, most recently at $559.7 million for Q4 2025.

  • Quarterly results put Total Debt at $559.7 million for Q4 2025, down 3.45% from a year ago — trailing twelve months through Dec 2025 was $559.7 million (down 3.45% YoY), and the annual figure for FY2025 was $559.7 million, down 3.45%.
  • Total Debt for Q4 2025 was $559.7 million at Collegium Pharmaceutical, down from $570.2 million in the prior quarter.
  • Over the last five years, Total Debt for COLL hit a ceiling of $630.3 million in Q3 2024 and a floor of $110.0 million in Q4 2021.
  • Median Total Debt over the past 5 years was $548.4 million (2023), compared with a mean of $448.8 million.
  • Biggest five-year swings in Total Debt: skyrocketed 409.07% in 2022 and later tumbled 35.9% in 2024.
  • Collegium Pharmaceutical's Total Debt stood at $110.0 million in 2021, then skyrocketed by 409.07% to $560.1 million in 2022, then fell by 27.68% to $405.0 million in 2023, then skyrocketed by 43.12% to $579.7 million in 2024, then decreased by 3.45% to $559.7 million in 2025.
  • The last three reported values for Total Debt were $559.7 million (Q4 2025), $570.2 million (Q3 2025), and $585.2 million (Q2 2025) per Business Quant data.